#LCSM Transcript
Healthcare social media transcript of the #LCSM hashtag.
– ().
See #LCSM Influencers/Analytics.
| Profile | Tweet |
|---|---|
 | Deena Cook @DeenaRoger RT @LungCancerFaces: ACTION ALERT! This is time sensitive. Deadline is March 10, so don’t delay. Please share far and wide. #lcsm |
 | annie Laing @grandma_hockey RT @MDAndersonNews: “These findings emphasize the need for clinical efforts to focus on rational combination therapies for treatment-naïve small cell #lungcancer tumors to maximize initial responses,” says our @LaurenByersMD. #lcsm #endcancer |
| Deena Cook @DeenaRoger RT @GO2Foundation: Use your voice to ask your House Representatives to increase the funding level for the #LungCancerResearchProgram. Your voice makes a difference to legislators, help us speak out as one and demand research dollars! #lcsm #lungcancer >> https://t.co/LGV50X935n https://t.co/AMd4mimLbs |
 | David Mezzoprete @DMezzoprete RT @RadiologyACR: A new study published in @JACRJournal found #mammography screening program directors are interested in leveraging their programs to educate women about #lungcancer screening via @AuntMinnie https://t.co/33vLRjXSqw #lcsm |
 | GO2 for Lung Cancer @GO2forLungCancr #WednesdayWisdom | Positivity can make a difference in your #lungcancer journey! #lcsm https://t.co/FpUU4jQIVV |
 | Bilal Piperdi @bpiperdi RT @notahedge: Just had a pt refuse definitive CRT for Stg III unresectable NSCLC to go and do THC oil. Why doesnt the US have laws against false advertising? And why isn't there more research to disprove or prove benefits of these alternative "therapies"? #lcsm |
 | @Father of Cats @MatGrano RT @TestLungCancer: When Dening Day, mom of PGA golf champion Jason Day, found out she had #lungcancer, she had questions and they were determined to find answers. Learn how getting a complete diagnosis helped them find a treatment right for her type of lung cancer. #LCSM |
 | Dr. Iván R. González @Dr_Ivanoncologo RT @StephenVLiu: #OncoAlert Exploration of the impact of #EGFR TKIs on the #TME @CCR_AACR. Analysis of 138 patients with EGFR+ #NSCLC who received a 1st gen EGFR TKI and had pre/post biopsies. Assayed changes in PD-L1 expression, TIL density and TME makeup. #LCSM https://t.co/7BG16yrrei |
 | Matthew Katz, MD 🟦 @subatomicdoc RT @lcsmchat: Why are so few cancer patients participating in clinical trials? There are many reasons. Let’s ID them & brainstorm solutions during #LCSM Chat Thurs 3/5 at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/GOSm3k107K… and please join the conversation! @CharuAggarwalMD https://t.co/rcxiSUCAtb |
 | ACS National Lung Cancer Roundtable @NLCRTnews RT @teamdraft: @MSDintheUK @RuthStraussFdn @chrisdraft @HouseofCommons @NFLLegends @chrisdraft shared our commitment to #changingthefaceoflungcancer @HouseofCommons #lcsm https://t.co/ypu57OuwqE |
 | Ohio State Radiology @OSURadiology RT @RadiologyACR: A new study published in @JACRJournal found #mammography screening program directors are interested in leveraging their programs to educate women about #lungcancer screening via @AuntMinnie https://t.co/33vLRjXSqw #lcsm |
 | Lisa Briggs @livinglife82 The patient experience from an oncology nurse come patient. She describes every part of the experience so well... No one expects you to ‘totally’ get it, but glad the experience has now helped you in a more positive way. #LCSM #Cancer #OncologyNurse https://t.co/llSa75wmiN |
 | Guneet Walia @GuneetWalia RT @trnsltnl: |
 | Becky Haines @grebeccahaines RT @teamdraft: @MSDintheUK @RuthStraussFdn @chrisdraft @HouseofCommons @NFLLegends @chrisdraft shared our commitment to #changingthefaceoflungcancer @HouseofCommons #lcsm https://t.co/ypu57OuwqE |
| Becky Haines @grebeccahaines RT @findlungcancer: Please join us Rescue Lung Rescue Life Society Conference dedicated to Lung Screening - May 1-2 Boston https://t.co/85aWrQzgl6 #lcsm @DrIanWeissman @lung_ca_screen @lcsmchat @DrewMoghanaki @grebeccahaines @EJFloresMD @sands_jacob @BrendonStilesMD @genentech @CancerGeek |
 | Katsuaki Maehara Ph.D. 🇯🇵 @KatsuakiMaehara RT @jillfeldman4: This is a great (yet scary) piece on our world today & what happens when science, scientists & health care providers are ignored, underfunded & under-appreciated #LCSM #Covid_19 #ScienceMatters https://t.co/0gof9jCuxM |
 | Tom Varghese Jr. MD, MS, MBA, FACS, MAMSE 🇺🇸 @TomVargheseJr RT @teamdraft: @MSDintheUK @RuthStraussFdn @chrisdraft @HouseofCommons @NFLLegends @chrisdraft shared our commitment to #changingthefaceoflungcancer @HouseofCommons #lcsm https://t.co/ypu57OuwqE |
 | Paula A @paulalv RT @trnsltnl: |
| Katsuaki Maehara Ph.D. 🇯🇵 @KatsuakiMaehara RT @ivybelkins: #lcsm |
 | Mary Anne Sterling @SterlingHIT RT @coffeemommy: @AdvBreastCa_HU Respectfully, we need to stop asking rhetorical questions. We KNOW that people with {insert disease/condition here} should be involved in design of all research including clinical trials. Making research person-centric will help accrual, retention AND dissemination #bcsm #lcsm |
 | Suzy Spencer @spencerwriter RT @GO2Foundation: Use your voice to ask your House Representatives to increase the funding level for the #LungCancerResearchProgram. Your voice makes a difference to legislators, help us speak out as one and demand research dollars! #lcsm #lungcancer >> https://t.co/LGV50X935n https://t.co/AMd4mimLbs |
 | DavidASirbasku @DSirbasku RT @MDAndersonNews: “These findings emphasize the need for clinical efforts to focus on rational combination therapies for treatment-naïve small cell #lungcancer tumors to maximize initial responses,” says our @LaurenByersMD. #lcsm #endcancer |
 | LM Jagoda @Ljagoda RT @TestLungCancer: When Dening Day, mom of PGA golf champion Jason Day, found out she had #lungcancer, she had questions and they were determined to find answers. Learn how getting a complete diagnosis helped them find a treatment right for her type of lung cancer. #LCSM |
 | jkeller @jkeller625 RT @TestLungCancer: When Dening Day, mom of PGA golf champion Jason Day, found out she had #lungcancer, she had questions and they were determined to find answers. Learn how getting a complete diagnosis helped them find a treatment right for her type of lung cancer. #LCSM |
 | OncoAlert @OncoAlert RT @LungCancerEu: |
 | Joseph Steward @jsteward2930 RT @LungCancerEu: |
 | cacaskata @cacaskata RT @LungCancerEu: |
 | OncLive SOSS @OncLiveSOSS .@aminmirhadi sheds light on patient populations of lung cancer optimal for radiation @CedarsSinai #lcsm https://t.co/P2zA0gMUDZ |
 | Pasquale Pisapia @PasqualePisapia RT @ChristianRolfo: Until March 13th you have time to send your abstract to #wclc2020 in Singapore! This is a unique forum for share your research and increase your networking! @IASLC @t_mitsudomi @danieltanmd @HwakeleeMD @giorgioscaglio3 #LCSM https://t.co/9gcwLDwGYI |
 | Rebecca Poehnelt @poehnelt RT @GO2Foundation: Use your voice to ask your House Representatives to increase the funding level for the #LungCancerResearchProgram. Your voice makes a difference to legislators, help us speak out as one and demand research dollars! #lcsm #lungcancer >> https://t.co/LGV50X935n https://t.co/AMd4mimLbs |
 | Pxel @Pxel_SA #MedEd #BCSM #HCLDR #HITsm #hpm #hcsmca #LCSM #MMSM #ESHREjc #EofL #ourD #NephJC #ArthritisIsSerious #wedns #BTSM #hcsmSA #JACR #SouthAfrica #Medical #Health #ThursdayThoughts #BlackTwitter #RT |
 | Christine Shusted, MPH @CSShusted RT @GO2Foundation: Use your voice to ask your House Representatives to increase the funding level for the #LungCancerResearchProgram. Your voice makes a difference to legislators, help us speak out as one and demand research dollars! #lcsm #lungcancer >> https://t.co/LGV50X935n https://t.co/AMd4mimLbs |
 | OncLive.com @OncLive The NELSON trial and National Lung Screening Trial demonstrated a decrease in lung cancer mortality for patients who are regularly screened with low-dose CT compared with single-view posteroanterior chest radiography #lcsm https://t.co/6KrKTEVCZ8 |
 | Tontarn Chutima @Tontarnnaja RT @OncLive: The NELSON trial and National Lung Screening Trial demonstrated a decrease in lung cancer mortality for patients who are regularly screened with low-dose CT compared with single-view posteroanterior chest radiography #lcsm https://t.co/6KrKTEVCZ8 |
 | Wilmot Cancer Institute @WilmotCancer A new @CDCgov study found only about 12.5% of patients for whom screening is recommended actually received it in the last year. Dr. Carolyn Jones recently talked with @MarkGruba about #lung cancer screening & how important it can be. #lcsm https://t.co/6nB9dHp638 |
| OncLive.com @OncLive The role of liquid biopsy has grown dramatically in #NSCLC, said @HatimHusainMD of @UCSDHealth, adding that implementing this testing modality for genomic markers may optimize treatment for newly diagnosed patients #lcsm https://t.co/UzMT7hhoOV |
 | Jill Hamer-Wilson 🇨🇦 @JillHW Brigatinib (Alunbrig) receives positive report for people with ALK lung cancer in Europe. Terrific news! Well done, @DrSanjayPopat and team! Thank you, @TakedaOncology #ALK #lungcancer #brigatinib #LCSM |
| Jill Hamer-Wilson 🇨🇦 @JillHW Lung cancer nurses are awesome! Way to go team! #Nurses #LCSM |
 | Annals of Oncology @Annals_Oncology TATTON published in Annals of Oncology is a phase Ib study testing the 3rd generation anti-EGFR TKI Osimertinib in combination with selumetinib (MEK1/2 inhibitor), savolitinib (MET-TKI), or durvalumab (anti-PD-L1) in EGFR-mutated NSCLC https://t.co/nxs6HUnLVp #LCSM @geoff_oxnard https://t.co/9QIb44EIP8 |
 | Jacques Raphael @JackRaph RT @Annals_Oncology: TATTON published in Annals of Oncology is a phase Ib study testing the 3rd generation anti-EGFR TKI Osimertinib in combination with selumetinib (MEK1/2 inhibitor), savolitinib (MET-TKI), or durvalumab (anti-PD-L1) in EGFR-mutated NSCLC https://t.co/nxs6HUnLVp #LCSM @geoff_oxnard https://t.co/9QIb44EIP8 |
 | Ann-Marie Gilbert @amg_LDM RT @SeleneSeltzer: Yes💯! Every interaction by anyone can be a #palliative approach to care/#caring 👉 to reduce #suffering. #intensivecaring #humansofPC #palliativecare #ayacsm #bcsm #btsm #gyncsm #crcsm #lcsm #lymsm #melsm #mmsm #pancsm #pcsm #cancer #COPD #CHD #CKD #dementia #ALS #ALZ #AIDS |
 | COPD_research @COPD_research RT @SeleneSeltzer: Yes💯! Every interaction by anyone can be a #palliative approach to care/#caring 👉 to reduce #suffering. #intensivecaring #humansofPC #palliativecare #ayacsm #bcsm #btsm #gyncsm #crcsm #lcsm #lymsm #melsm #mmsm #pancsm #pcsm #cancer #COPD #CHD #CKD #dementia #ALS #ALZ #AIDS |
 | Faces of Lung Cancer @LungCancerFaces TODAY! Why aren’t more cancer patients participating in clinical trials? There are a number of reasons. Let’s identify them & brainstorm solutions during #LCSM Chat on 3/5 at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/wgowzlv9z2… and join the conversation! #hcsm https://t.co/HY8LbZ8Zea |
 | MD Anderson Leukemia @LeukemiaMDA RT @mtmdphd: Organizing Online Health Content: Organizing Online Health Content: Developing Hashtag Collections for Healthier Internet-Based People and Communities [Jun 28, 2019] @subatomicdoc et al. #JCOCCI https://t.co/776r7qmxcY #ayacsm #bcsm #btsm #gyncsm #lcsm #mmsm #pancsm https://t.co/gAWd15peeW |
 | Inspire @InspireIsHealth RT @LungCancerFaces: TODAY! Why aren’t more cancer patients participating in clinical trials? There are a number of reasons. Let’s identify them & brainstorm solutions during #LCSM Chat on 3/5 at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/wgowzlv9z2… and join the conversation! #hcsm https://t.co/HY8LbZ8Zea |
 | #LCSM Chat @lcsmchat TODAY! Why are so few cancer patients participating in clinical trials? There are many reasons. Let’s ID them & brainstorm solutions during #LCSM Chat 3/5 at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/GOSm3k107K… and please join the conversation! #bcsm #gyncsm #btsm https://t.co/7P6KmVgucf |
 | Dear Dr. Researcher, PhD @corrie_painter RT @lcsmchat: TODAY! Why are so few cancer patients participating in clinical trials? There are many reasons. Let’s ID them & brainstorm solutions during #LCSM Chat 3/5 at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/GOSm3k107K… and please join the conversation! #bcsm #gyncsm #btsm https://t.co/7P6KmVgucf |
| OncoAlert @OncoAlert RT @Annals_Oncology: TATTON published in Annals of Oncology is a phase Ib study testing the 3rd generation anti-EGFR TKI Osimertinib in combination with selumetinib (MEK1/2 inhibitor), savolitinib (MET-TKI), or durvalumab (anti-PD-L1) in EGFR-mutated NSCLC https://t.co/nxs6HUnLVp #LCSM @geoff_oxnard https://t.co/9QIb44EIP8 |
 | Jillian Barberie @askjillian You’re allowed. Be kind to yourself. I understand your frustration. It’s so hard!! |
 | DawnKA Official Cheerleader for Good of Humanity🎉 @DawnKA RT @OncLive: The NELSON trial and National Lung Screening Trial demonstrated a decrease in lung cancer mortality for patients who are regularly screened with low-dose CT compared with single-view posteroanterior chest radiography #lcsm https://t.co/6KrKTEVCZ8 |
| DawnKA Official Cheerleader for Good of Humanity🎉 @DawnKA RT @MDAndersonNews: “These findings emphasize the need for clinical efforts to focus on rational combination therapies for treatment-naïve small cell #lungcancer tumors to maximize initial responses,” says our @LaurenByersMD. #lcsm #endcancer |
 | Kelli Oddo @KelliOddo RT @LungCancerFaces: ACTION ALERT! This is time sensitive. Deadline is March 10, so don’t delay. Please share far and wide. #lcsm |
 | Tiffini Joseph @Smiles4Nana RT @lcsmchat: TODAY! Why are so few cancer patients participating in clinical trials? There are many reasons. Let’s ID them & brainstorm solutions during #LCSM Chat 3/5 at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/GOSm3k107K… and please join the conversation! #bcsm #gyncsm #btsm https://t.co/7P6KmVgucf |
 | Janet Freeman-Daily @JFreemanDaily It's amazing how much you can get done when you're told to stay home (I'm 60+ and have an underlying condition--being treated for #lungcancer). Even some of my online meetings for #Seattle events are getting canceled because of #COVIDSeattle. #LCSM |
| OncLive SOSS @OncLiveSOSS Biomarker-Driven NSCLC Paradigm Advances With Novel Agents, Liquid Biopsies @UCLAJCCC #lcsm Read the article: https://t.co/2Lx2ZWRPUx |
 | Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @lcsmchat: TODAY! Why are so few cancer patients participating in clinical trials? There are many reasons. Let’s ID them & brainstorm solutions during #LCSM Chat 3/5 at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/GOSm3k107K… and please join the conversation! #bcsm #gyncsm #btsm https://t.co/7P6KmVgucf |
 | Livin’ life like its golden @skinnyfabulous_ RT @LungCancerFaces: ACTION ALERT! This is time sensitive. Deadline is March 10, so don’t delay. Please share far and wide. #lcsm |
 | Drew Moghanaki 🐕 @DrewMoghanaki Look @BrendonStilesMD. 👀 We too can now see the tumor while it’s being eradicated. #lcsm #radonc @tssmn |
 | Jim Selikoff @JSelikoff RT @DrewMoghanaki: Look @BrendonStilesMD. 👀 We too can now see the tumor while it’s being eradicated. #lcsm #radonc @tssmn |
 | Christine Qiong Wu @CQiongWu RT @livinglife82: The patient experience from an oncology nurse come patient. She describes every part of the experience so well... No one expects you to ‘totally’ get it, but glad the experience has now helped you in a more positive way. #LCSM #Cancer #OncologyNurse https://t.co/llSa75wmiN |
| Christine Shusted, MPH @CSShusted Dr. Julie Barta highlighting the importance of annual adherence to lung cancer screening #GetScreened #LungCancer #LCSM https://t.co/MKDA9qtUYz |
| Christine Shusted, MPH @CSShusted Dr. Rickie Brawer shares quotes from persons eligible for lung cancer screening regarding #stigma #LCSM @TJUHospital @JeffersonJCPH https://t.co/jboFqbksps |
| Jill Hamer-Wilson 🇨🇦 @JillHW Lung cancer is not preventable. Anyone can get it. Everyone who gets it deserves compassion. Great video! Thank you Lindi @breathofhopeky and team for raising your voices together to educate! Great teamwork! #lungcancer #compassion #team #lcsm https://t.co/oaTiO1gDYq |
 | Greater Charlotte Area ONS @gcaons RT @cure_magazine: CURE is pleased to announce the opening for nominations for the inaugural Lung Cancer Heroes™ awards program! Learn more about this event here: #lcsm #lungcancer https://t.co/dPdcElBcbM |
 | Kim Moran-MacIntosh 🇨🇦 🍀 @Kamacintosh RT @jillfeldman4: This is a great (yet scary) piece on our world today & what happens when science, scientists & health care providers are ignored, underfunded & under-appreciated #LCSM #Covid_19 #ScienceMatters https://t.co/0gof9jCuxM |
| Christine Shusted, MPH @CSShusted “People will keep it a secret. So, you may not want to go and have any testing done because you don’t want people to know that you smoke. You’re not supposed to smoke and be a church member....” an African American key informant shared #LCSM |
 | Dr. Zeynep Hülya Gümüş 🕊️ @ZeynepHG RT @notahedge: Just had a pt refuse definitive CRT for Stg III unresectable NSCLC to go and do THC oil. Why doesnt the US have laws against false advertising? And why isn't there more research to disprove or prove benefits of these alternative "therapies"? #lcsm |
 | Population Health @JeffersonJCPH RT @CSShusted: Dr. Rickie Brawer shares quotes from persons eligible for lung cancer screening regarding #stigma #LCSM @TJUHospital @JeffersonJCPH https://t.co/jboFqbksps |
| Christine Shusted, MPH @CSShusted “Okay this is surreal, this is the beginning of my journey” - lung cancer patient on hearing they had a suspicious nodule at the 8th annual Lung Cancer Symposium @TJUHospital #LCSM #GetScreened |
| OncLive.com @OncLive Between the approvals of next-generation TKIs as go-to frontline regimens for patients with EGFR+ and ALK+ #NSCLC and the utility of liquid biopsies, these advances have transformed the paradigm of biomarker-driven disease #lcsm https://t.co/RgiLD71RRj |
| Christine Shusted, MPH @CSShusted “The first thing people assume when you say lung cancer is that you are a smoker, but I wasn’t” - lung cancer survivor #LCSM #stigma |
 | GYN Cancer | #GYNCSM @gyncsm RT @lcsmchat: TODAY! Why are so few cancer patients participating in clinical trials? There are many reasons. Let’s ID them & brainstorm solutions during #LCSM Chat 3/5 at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/GOSm3k107K… and please join the conversation! #bcsm #gyncsm #btsm https://t.co/7P6KmVgucf |
 | Cancer Commons @cancercommons Molecular test "results can take three to four weeks—and that’s simply too long to make treatment decisions." Curious Dr. George asks David Spigel, MD, about the state of molecular testing in #lungcancer: https://t.co/PTXo063Cot #LCSM |
| Katsuaki Maehara Ph.D. 🇯🇵 @KatsuakiMaehara RT @Annals_Oncology: TATTON published in Annals of Oncology is a phase Ib study testing the 3rd generation anti-EGFR TKI Osimertinib in combination with selumetinib (MEK1/2 inhibitor), savolitinib (MET-TKI), or durvalumab (anti-PD-L1) in EGFR-mutated NSCLC https://t.co/nxs6HUnLVp #LCSM @geoff_oxnard https://t.co/9QIb44EIP8 |
 | Dr. Deanna Attai @DrAttai RT @lcsmchat: TODAY! Why are so few cancer patients participating in clinical trials? There are many reasons. Let’s ID them & brainstorm solutions during #LCSM Chat 3/5 at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/GOSm3k107K… and please join the conversation! #bcsm #gyncsm #btsm https://t.co/7P6KmVgucf |
| Jill Hamer-Wilson 🇨🇦 @JillHW Lung cancer screening matters! Way to go, Sydney Uni! #lcsm |
| GO2 for Lung Cancer @GO2forLungCancr “We are grateful for @BiodesixInc leadership in developing tests that help patients to know what their risk level is for #lungcancer” -@bonniejaddario Read more from @ClinicalOMICs on developments in simple liquid biopsys. #lcsm >> https://t.co/ZfjLJ9x7dE |
 | Lung Cancer Mgmt Jnl @fsglmt Our latest #openaccess research article estimates the cost of #BrainMetastases in patients with advanced ALK+ #NSCLC https://t.co/wf7nqnEKTy #lungcancer #LCSM https://t.co/7sJDHHUyya |
 | AnCan Foundation @ancan501c3 #clinicaltrials don't always report, timely or otherwise! See @ScienceMagazine & our Blog post https://t.co/ObC4piH4rN @PCFnews @PCF_Science #bcsm #BTSM #LCSM #ProstateCancer @LCAorg #lungcancer #Cancers #Melanoma #colorectalcancer @MBCC_MHBT #Cancer #kidneycancer #caregivers |
 | Ashley Lilly @AshleyCLilly82 RT @CEC_Onc: Join us Fri 3/13 in Tampa at #HOPAAhead2020 for a dynamic discussion on biomarker testing & #PrecisionMedicine in #NSCLC #lcsm #oncopharm 👩🏼💼Register to attend: https://t.co/bzwAybh971 🖥Live webcast: https://t.co/pFe8LlH7mM •1.0 hr ACPE credit @josiahdavidrx @ZPiotrowskaMD https://t.co/QGt6Gsobsg |
 | JAMA Oncology @JAMAOnc Cohort study shows genome-wide micro-RNA profiles from blood samples in >3000 ppl identifies patients with #LungCancer w 91.4% accuracy, 82.8% sensitivity, & 93.5% specificity, showing patterns of circulating microRNA may complement screening scans https://t.co/9zbHHpKP9K #LCSM |
 | Boehringer Ingelheim @boehringerus Ivy’s #lungcancer journey inspires us to give patients new hope by #TakingCancerOn. What motivates you? #LCSM https://t.co/0L8a3uutqM |
 | Khadijah @khadijah1411 RT @JAMAOnc: Cohort study shows genome-wide micro-RNA profiles from blood samples in >3000 ppl identifies patients with #LungCancer w 91.4% accuracy, 82.8% sensitivity, & 93.5% specificity, showing patterns of circulating microRNA may complement screening scans https://t.co/9zbHHpKP9K #LCSM |
| OncoAlert @OncoAlert RT @aftimosp: |
 | Adela @adelapoite RT @JAMAOnc: Cohort study shows genome-wide micro-RNA profiles from blood samples in >3000 ppl identifies patients with #LungCancer w 91.4% accuracy, 82.8% sensitivity, & 93.5% specificity, showing patterns of circulating microRNA may complement screening scans https://t.co/9zbHHpKP9K #LCSM |
 | SCLC Support Group @SCLCSupport The latest The SCLC Support Community: News Round-Up! https://t.co/RJ9TQXf35o Thanks to @GO2Foundation @StupidCancer #lungcancer #lcsm |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD TimAllenMDJD: Update on emerging biomarkers in #LungCancer #LCSM https://t.co/iwngx7ZsgE |
 | Andres F. Cardona @AndresFCardonaZ RT @NatRevClinOncol: |
 | Gonzalo Recondo @GRecondoMD @LauraMezquitaMD on the clinical utility of developing precision medicine programs for the daily clinical practice. #lcsm . https://t.co/NmiGI4fIel |
 | Rhianna Rita Starr @rhianna RT @TimAllenMDJD: TimAllenMDJD: TimAllenMDJD: Update on emerging biomarkers in #LungCancer #LCSM https://t.co/iwngx7ZsgE |
 | Minas Chrysopoulo MD FACS @drchrysopoulo RT @lcsmchat: TODAY! Why are so few cancer patients participating in clinical trials? There are many reasons. Let’s ID them & brainstorm solutions during #LCSM Chat 3/5 at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/GOSm3k107K… and please join the conversation! #bcsm #gyncsm #btsm https://t.co/7P6KmVgucf |
 | SeleneSeltzer @SeleneSeltzer TY @bermudababe76!👇THIS👇❤️💔sums up the plight of the #carepartner/#caregiver/#carer for loved ones w/#seriousillness. #humansofPC #palliativecare #hapc #btsm #bcsm #ayacsm #gyncsm #crcsm #lcsm #lymsm #melsm #mmsm #pancsm #pcsm #cancer #COPD #CHD #CKD #dementia #ALS #ALZ #AIDS |
| COPD_research @COPD_research RT @SeleneSeltzer: TY @bermudababe76!👇THIS👇❤️💔sums up the plight of the #carepartner/#caregiver/#carer for loved ones w/#seriousillness. #humansofPC #palliativecare #hapc #btsm #bcsm #ayacsm #gyncsm #crcsm #lcsm #lymsm #melsm #mmsm #pancsm #pcsm #cancer #COPD #CHD #CKD #dementia #ALS #ALZ #AIDS |
 | Geoff Oxnard MD @geoff_oxnard RT @Annals_Oncology: TATTON published in Annals of Oncology is a phase Ib study testing the 3rd generation anti-EGFR TKI Osimertinib in combination with selumetinib (MEK1/2 inhibitor), savolitinib (MET-TKI), or durvalumab (anti-PD-L1) in EGFR-mutated NSCLC https://t.co/nxs6HUnLVp #LCSM @geoff_oxnard https://t.co/9QIb44EIP8 |
 | Satyam Singh @satyamsingh2704 RT @StephenVLiu: #OncoAlert Exploration of the impact of #EGFR TKIs on the #TME @CCR_AACR. Analysis of 138 patients with EGFR+ #NSCLC who received a 1st gen EGFR TKI and had pre/post biopsies. Assayed changes in PD-L1 expression, TIL density and TME makeup. #LCSM https://t.co/7BG16yrrei |
 | V. H. Hammontree @sawb3 RT @TestLungCancer: When Dening Day, mom of PGA golf champion Jason Day, found out she had #lungcancer, she had questions and they were determined to find answers. Learn how getting a complete diagnosis helped them find a treatment right for her type of lung cancer. #LCSM |
| Dr. Iván R. González @Dr_Ivanoncologo @AACR | #MAPK pathway alterations correlate with poor survival and drive resistance to therapy in patients with lung cancers driven by #ROS1 fusions | Article: 🔎https://t.co/nJAJ7cb31k #LungCancer #lcsm https://t.co/7a78JSwfXx |
 | Susan Holz @Susanholz11 RT @boehringerus: Ivy’s #lungcancer journey inspires us to give patients new hope by #TakingCancerOn. What motivates you? #LCSM https://t.co/0L8a3uutqM |
 | Penn Medicine MD @PennMDForum RT @LungSummit: ... and he will be just as outstanding as last year. We are very happy to have @Jbauml with us and learn more about #immunotherapy options for #lungcancer patients. #LungSummit #LCSM |
 | David Russler-Germain, MD/PhD @dgermain21 RT @NatRevClinOncol: |
 | Targeted Oncology @TargetedOnc RT @CancerResearch: Dr. Stephen Liu of @MedStarGUH explains genetic testing in patients with non-small cell lung cancer. Via @TargetedOnc #nsclc #lcsm https://t.co/zgtxqYkliL |
| Deena Cook @DeenaRoger URGENT REQUEST: please tell your elected Member of CONGRESS to support additional research funding for lung cancer. Deadline March 10; Let’s DO this! #LCSM #lcam |
 | Joanne (she/her) @GonnyGolightly RT @LungCancerFaces: ACTION ALERT! This is time sensitive. Deadline is March 10, so don’t delay. Please share far and wide. #lcsm |
| Joanne (she/her) @GonnyGolightly RT @DeenaRoger: URGENT REQUEST: URGENT REQUEST: please tell your elected Member of CONGRESS to support additional research funding for lung cancer. Deadline March 10; Let’s DO this! #LCSM #lcam |
| Joanne (she/her) @GonnyGolightly RT @ChristianRolfo: Until March 13th you have time to send your abstract to #wclc2020 in Singapore! This is a unique forum for share your research and increase your networking! @IASLC @t_mitsudomi @danieltanmd @HwakeleeMD @giorgioscaglio3 #LCSM https://t.co/9gcwLDwGYI |
 | Oncology @PracUpOnc The Impact of Anlotinib on #NSCLC Brain Metastases https://t.co/8hgF8jRZhB #lcsm |
 | Coronavirus Brasil @EstimativasB RT @JAMAOnc: Cohort study shows genome-wide micro-RNA profiles from blood samples in >3000 ppl identifies patients with #LungCancer w 91.4% accuracy, 82.8% sensitivity, & 93.5% specificity, showing patterns of circulating microRNA may complement screening scans https://t.co/9zbHHpKP9K #LCSM |
| Janet Freeman-Daily @JFreemanDaily @TimAllenMDJD It's tough to balance maintaining calm for the majority of the population while still communicating the potential deadly consequences of this virus for those of us who are older and/or have underlying health conditions--like everyone living with #lungcancer. #LCSM |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @JFreemanDaily: @TimAllenMDJD It's tough to balance maintaining calm for the majority of the population while still communicating the potential deadly consequences of this virus for those of us who are older and/or have underlying health conditions--like everyone living with #lungcancer. #LCSM |
 | ICES @ICESOntario RT @dhirparaMD: Thrilled to share our @ICESOntario @OncologyAdvance paper highlighting an unmet need in stage 1-3 #lungcancer patients who reported severe physical & psychological symptoms up to 1 year after diagnosis! #lcsm #tssmn @tssmn Paper: https://t.co/EKu982vBwR |
| Targeted Oncology @TargetedOnc Changes in the tumor microenvironment following progression on EGFR TKI therapy suggest a potential for benefit from PD-1/PD-L1 inhibitors in patients with EGFR+ NSCLC. https://t.co/Lc5o3irwFi #lcsm |
| OncoAlert @OncoAlert RT @lcsmchat: TODAY! Why are so few cancer patients participating in clinical trials? There are many reasons. Let’s ID them & brainstorm solutions during #LCSM Chat 3/5 at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/GOSm3k107K… and please join the conversation! #bcsm #gyncsm #btsm https://t.co/7P6KmVgucf |
 | José Máximo Barros, MD 🇦🇷 @barrosonco Felicitaciones @NicolasMinatta y @MariaBluthgen excelente día de aprendizaje en diagnóstico y secuenciación del #cancerdepulmon #lcsm @LauraMezquitaMD @GRecondoMD @RocheLatam #nuevageneración 💪 https://t.co/HJrBXTgM0c |
| Faces of Lung Cancer @LungCancerFaces RT @lcsmchat: TODAY! Why are so few cancer patients participating in clinical trials? There are many reasons. Let’s ID them & brainstorm solutions during #LCSM Chat 3/5 at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/GOSm3k107K… and please join the conversation! #bcsm #gyncsm #btsm https://t.co/7P6KmVgucf |
| #LCSM Chat @lcsmchat RT @LungCancerFaces: Why aren’t more cancer patients participating in clinical trials? There are a number of reasons. Let’s identify them & brainstorm solutions during this Thursday’s #LCSM Chat at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/vtXd2kPKyi and join the conversation! #hcsm https://t.co/HOK9DSAzwA |
 | Lauren Meehan Machos, MPH @LaurenMachos RT @LungCancerFaces: Why aren’t more cancer patients participating in clinical trials? There are a number of reasons. Let’s identify them & brainstorm solutions during this Thursday’s #LCSM Chat at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/vtXd2kPKyi and join the conversation! #hcsm https://t.co/HOK9DSAzwA |
 | JTO & JTO CRR @JTOonline Longitudinal evaluation of mutations in blood was a secondary objective in the BELIEF trial. In this article, Molina-Vila and colleagues report testing results and explore the correlation of EGFR status in blood with clinical outcomes. #LCSM https://t.co/rWJo0DhsfJ https://t.co/z7fL8g9WCH |
 | Charu Aggarwal, MD, MPH, FASCO @CharuAggarwalMD Circulating MicroRNA Profiles useful biomarker for Lung Cancer Detection in Symptomatic Patients. This is a vy important study that details a complementary modality to increase detection of #NSCLC @JAMAOnc #LiquidBiopsy @lcsmchat #LCSM https://t.co/kWZOt4xo7w |
 | Arturo LoAIza-Bonilla, MD MSEd @DrBonillaOnc RT @CharuAggarwalMD: Circulating MicroRNA Profiles useful biomarker for Lung Cancer Detection in Symptomatic Patients. This is a vy important study that details a complementary modality to increase detection of #NSCLC @JAMAOnc #LiquidBiopsy @lcsmchat #LCSM https://t.co/kWZOt4xo7w |
| Charu Aggarwal, MD, MPH, FASCO @CharuAggarwalMD @OncoAlert |
 | NicoMinatta @NicolasMinatta RT @barrosonco: Felicitaciones @NicolasMinatta y @MariaBluthgen excelente día de aprendizaje en diagnóstico y secuenciación del #cancerdepulmon #lcsm @LauraMezquitaMD @GRecondoMD @RocheLatam #nuevageneración 💪 https://t.co/HJrBXTgM0c |
| Andres F. Cardona @AndresFCardonaZ RT @CharuAggarwalMD: Circulating MicroRNA Profiles useful biomarker for Lung Cancer Detection in Symptomatic Patients. This is a vy important study that details a complementary modality to increase detection of #NSCLC @JAMAOnc #LiquidBiopsy @lcsmchat #LCSM https://t.co/kWZOt4xo7w |
 | Bill Schrul @bschrul @1111linno This is amazing. Tears in my eyes while watching it. #LCSM #clinicaltrials |
 | Qrank.gg @Qrankgg planning on leaving the house today? or sometime this month? this guide will have you lookin' fresh. 👟👞👠 #esportsfashion #LEC #LCSM https://t.co/kvWf3k5wMH |
 | IASLC @IASLC RT @JTOonline: Longitudinal evaluation of mutations in blood was a secondary objective in the BELIEF trial. In this article, Molina-Vila and colleagues report testing results and explore the correlation of EGFR status in blood with clinical outcomes. #LCSM https://t.co/rWJo0DhsfJ https://t.co/z7fL8g9WCH |
| Gonzalo Recondo @GRecondoMD RT @barrosonco: Felicitaciones @NicolasMinatta y @MariaBluthgen excelente día de aprendizaje en diagnóstico y secuenciación del #cancerdepulmon #lcsm @LauraMezquitaMD @GRecondoMD @RocheLatam #nuevageneración 💪 https://t.co/HJrBXTgM0c |
| Janet Freeman-Daily @JFreemanDaily Why aren’t more cancer patients participating in clinical trials? Let’s identify the reasons & brainstorm solutions during today’s #LCSM Chat at 8 pm Eastern/5 pm Pacific. Read more at https://t.co/KBsE6cSmaG then join the conversation! #hcsm #BCSM #BTSM #GYNCSM #MMSM #CRCSM https://t.co/tTOKoPaDJC |
| Inspire @InspireIsHealth RT @JFreemanDaily: Why aren’t more cancer patients participating in clinical trials? Let’s identify the reasons & brainstorm solutions during today’s #LCSM Chat at 8 pm Eastern/5 pm Pacific. Read more at https://t.co/KBsE6cSmaG then join the conversation! #hcsm #BCSM #BTSM #GYNCSM #MMSM #CRCSM https://t.co/tTOKoPaDJC |
 | PER @gotoPER RT @TargetedOnc: Changes in the tumor microenvironment following progression on EGFR TKI therapy suggest a potential for benefit from PD-1/PD-L1 inhibitors in patients with EGFR+ NSCLC. https://t.co/Lc5o3irwFi #lcsm |
 | Erika Hlavacek @ErikaHlavacek RT @GinaHollenbeck: Could this be the way we screen for lung cancer in the future? https://t.co/7XdYz7dn2B #LCSM |
 | Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @JFreemanDaily Looking forward to the dialogue and diverse community perspectives! #bcsm #btsm #gyncsm #lcsm #mmsm #pancsm #cancer #clinicaltrials |
 | Maria Virginia Bluthgen @MariaBluthgen #masterclass Cancer de Pulmón. @NicolasMinatta @GRecondoMD @LauraMezquitaMD #LCSM https://t.co/KJyWHTik7c |
| Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD RT @JFreemanDaily: Why aren’t more cancer patients participating in clinical trials? Let’s identify the reasons & brainstorm solutions during today’s #LCSM Chat at 8 pm Eastern/5 pm Pacific. Read more at https://t.co/KBsE6cSmaG then join the conversation! #hcsm #BCSM #BTSM #GYNCSM #MMSM #CRCSM https://t.co/tTOKoPaDJC |
 | Lillian Leigh GAICD @ProjectBreath I spoke at the recent #ALCC2020 about the need to expand eligibility criteria. Here's another example! #DiverseResearch #clinicaltrials #lcsm @cancer_K2A https://t.co/XoBFCxVpzz |
| Kim Moran-MacIntosh 🇨🇦 🍀 @Kamacintosh RT @LungCancerFaces: Why aren’t more cancer patients participating in clinical trials? There are a number of reasons. Let’s identify them & brainstorm solutions during this Thursday’s #LCSM Chat at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/vtXd2kPKyi and join the conversation! #hcsm https://t.co/HOK9DSAzwA |
 | Aditya Pathak @APathak0385 RT @Annals_Oncology: TATTON published in Annals of Oncology is a phase Ib study testing the 3rd generation anti-EGFR TKI Osimertinib in combination with selumetinib (MEK1/2 inhibitor), savolitinib (MET-TKI), or durvalumab (anti-PD-L1) in EGFR-mutated NSCLC https://t.co/nxs6HUnLVp #LCSM @geoff_oxnard https://t.co/9QIb44EIP8 |
| Janet Freeman-Daily @JFreemanDaily @ProjectBreath @cancer_K2A Hope you'll share some of these during #LCSM Chat tonight, Lillian! |
 | Nicholas Borelli @BorelliBooks RT @boehringerus: Ivy’s #lungcancer journey inspires us to give patients new hope by #TakingCancerOn. What motivates you? #LCSM https://t.co/0L8a3uutqM |
 | Lou War @TumorWarrior Top story: #LCSM Chat Topic 3/5/2020: Expanding Access to Cancer Clinical Trials | #LCSM https://t.co/AN9n3ALhCF, see more https://t.co/rb2MBv6zsm |
| doraine shipley @GiliwayaDoraine RT @boehringerus: Ivy’s #lungcancer journey inspires us to give patients new hope by #TakingCancerOn. What motivates you? #LCSM https://t.co/0L8a3uutqM |
 | LungCancer.net @LungCancer_HU RT @LungCancerFaces: Why aren’t more cancer patients participating in clinical trials? There are a number of reasons. Let’s identify them & brainstorm solutions during this Thursday’s #LCSM Chat at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/vtXd2kPKyi and join the conversation! #hcsm https://t.co/HOK9DSAzwA |
 | Christina Lizaso @btrfly12 RT @LungCancerFaces: Why aren’t more cancer patients participating in clinical trials? There are a number of reasons. Let’s identify them & brainstorm solutions during this Thursday’s #LCSM Chat at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/vtXd2kPKyi and join the conversation! #hcsm https://t.co/HOK9DSAzwA |
 | RadiOncBOTjp @RadiOncBOTjp RT @DrewMoghanaki: Look @BrendonStilesMD. 👀 We too can now see the tumor while it’s being eradicated. #lcsm #radonc @tssmn |
| IASLC @IASLC Many individuals who are at high risk of lung cancer are not eligible for screening by U.S. Preventive Services Task Force (USPSTF) guidelines according to a new study. #LCSM #EarlyDetection https://t.co/Js8NLgZ32G |
| Janet Freeman-Daily @JFreemanDaily IN 45 MINUTES! Join #LCSM Chat for a discussion of ways to increase access to clinical trials. Read the blog at https://t.co/KBsE6cSmaG then join @coffeemommy and me on Twitter at 5 PM Pacific (8 pm Eastern). Learn how to join the chat here: https://t.co/5g28sSQQLb |
 | Showtime @withspin RT @JFreemanDaily: IN 45 MINUTES! Join #LCSM Chat for a discussion of ways to increase access to clinical trials. Read the blog at https://t.co/KBsE6cSmaG then join @coffeemommy and me on Twitter at 5 PM Pacific (8 pm Eastern). Learn how to join the chat here: https://t.co/5g28sSQQLb |
 | NTXCordBloodEducatorSheila @spurringtonNTX #endcancer this is very true. Reposting for personal |
 | mary casanova @mesolucky000 Fabulous news 🙏🏽 |
| Dr. Iván R. González @Dr_Ivanoncologo RT @Annals_Oncology: TATTON published in Annals of Oncology is a phase Ib study testing the 3rd generation anti-EGFR TKI Osimertinib in combination with selumetinib (MEK1/2 inhibitor), savolitinib (MET-TKI), or durvalumab (anti-PD-L1) in EGFR-mutated NSCLC https://t.co/nxs6HUnLVp #LCSM @geoff_oxnard https://t.co/9QIb44EIP8 |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @JFreemanDaily ⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️ All are welcome and bring your ideas! #bcsm #btsm #crcsm #gyncsm #lcsm #mmsm #cancer #clinicaltrials #patientexperience #hcldr |
 | b_hring_m @b_hring_m RT @JAMAOnc: Cohort study shows genome-wide micro-RNA profiles from blood samples in >3000 ppl identifies patients with #LungCancer w 91.4% accuracy, 82.8% sensitivity, & 93.5% specificity, showing patterns of circulating microRNA may complement screening scans https://t.co/9zbHHpKP9K #LCSM |
 | DJ GOTITALL @DJ_GOT_IT_ALL RT @boehringerus: Ivy’s #lungcancer journey inspires us to give patients new hope by #TakingCancerOn. What motivates you? #LCSM https://t.co/0L8a3uutqM |
 | Brendon Stiles @BrendonStilesMD @ALKLungCancer @lcrf_org @SurvivorNetTeam Let’s do it. One of our grants this year evaluates effects of gender on immunotherapy response. https://t.co/quSRGOqH1g We can do more! #lcsm @lcrf_org |
| Jill Hamer-Wilson 🇨🇦 @JillHW Thank you @DugaldSeely, awesome Anne Pitman, @OICCFoundation and @OICCSupport for terrific inaugural "Inspire Now" 6 wk program for people affected by #lungcancer. We appreciate you requesting input from #survivors @A_Redway & me as you developed it. Great work! #Ottawa #LCSM https://t.co/C7bEQ0pXRG |
| Janet Freeman-Daily @JFreemanDaily IN 15 MINUTES, #LCSM Chat will discuss expanding access to #cancer #clinicaltrials. Are you ready? |
 | Alice Berger @aliceb_phd RT @JFreemanDaily: IN 15 MINUTES, #LCSM Chat will discuss expanding access to #cancer #clinicaltrials. Are you ready? |
| mary casanova @mesolucky000 RT @jillfeldman4: We’ve come so far in discovery & treatment for #NSCLC, but small cell continues to be challenging. Advancements have been minimal with very modest impact. #SmallCell desperately needs research that leads to new & better treatment options #LCSM #lung20 #SmallCellMatters! https://t.co/UViLtj50uJ |
| mary casanova @mesolucky000 Praying for it ❤️ |
 | ☮️🇺🇦🇺🇦🇺🇦🏳️🌈🆘🆘🆘community comic @backspring2011 RT @boehringerus: Ivy’s #lungcancer journey inspires us to give patients new hope by #TakingCancerOn. What motivates you? #LCSM https://t.co/0L8a3uutqM |
 | @healthprivacy @HealthPrivacy RT @coffeemommy: @JFreemanDaily ⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️⬆️ All are welcome and bring your ideas! #bcsm #btsm #crcsm #gyncsm #lcsm #mmsm #cancer #clinicaltrials #patientexperience #hcldr |
| Deena Cook @DeenaRoger @JJKmyers @GO2Foundation Done! Can you say the same? If not PLEASE add your voice to increase lung cancer research #lcsm #lcam |
 | OurWarOnCancer @OurWarOnCancer RT @GO2Foundation: Use your voice to ask your House Representatives to increase the funding level for the #LungCancerResearchProgram. Your voice makes a difference to legislators, help us speak out as one and demand research dollars! #lcsm #lungcancer >> https://t.co/LGV50X935n https://t.co/AMd4mimLbs |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy In 2 minutes I'll be joining @JFreemanDaily to discuss "Expanding Access to Cancer Clinical Trials" as part of #lcsm chat so please join in or excuse my excess tweets. If you're around, we'd like to welcome anyone from the #cancer community to share their thoughts. #bcsm #gyncsm |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: Why aren’t more cancer patients participating in clinical trials? Let’s identify the reasons & brainstorm solutions during today’s #LCSM Chat at 8 pm Eastern/5 pm Pacific. Read more at https://t.co/KBsE6cSmaG then join the conversation! #hcsm #BCSM #BTSM #GYNCSM #MMSM #CRCSM https://t.co/tTOKoPaDJC |
| Janet Freeman-Daily @JFreemanDaily Welcome to #LCSM Chat! Tonight we will be discussing “Expanding Access to Cancer Clinical Trials.” More info on our blog at https://t.co/KBsE6cSmaG |
| Tiffini Joseph @Smiles4Nana RT @JFreemanDaily: Welcome to #LCSM Chat! Tonight we will be discussing “Expanding Access to Cancer Clinical Trials.” More info on our blog at https://t.co/KBsE6cSmaG |
| Janet Freeman-Daily @JFreemanDaily I’m your moderator Janet Freeman-Daily (writer, science geek, #lungcancer patient/research advocate). With me is tonight’s special guest Stacey Tinianov (@coffeemommy), #breastcancer patient/research advocate extraordinaire. Welcome Stacey! #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @JFreemanDaily Waving (and virtual elbow-tapping?!?) from Northern California, thrilled to be here with you all #lcsm |
| Janet Freeman-Daily @JFreemanDaily We'll get started in a few minutes -- please take a moment to introduce yourselves #LCSM |
 | kristen kimball @KimballKristen @JFreemanDaily @coffeemommy It’s Kris, signing in properly this time w/ hashtag #LCSM, still from Boston! |
 | Alicia C. Staley @stales RT @JFreemanDaily: Welcome to #LCSM Chat! Tonight we will be discussing “Expanding Access to Cancer Clinical Trials.” More info on our blog at https://t.co/KBsE6cSmaG |
| Tiffini Joseph @Smiles4Nana Tiffini Joseph joining from south Florida. Hi everyone #LCSM |
| Janet Freeman-Daily @JFreemanDaily @KimballKristen @coffeemommy Welcome Kris! #LCSM Glad you could join us. |
| Christine Qiong Wu @CQiongWu @JFreemanDaily @coffeemommy I'm here, Christine. #lcsm |
| Alicia C. Staley @stales @JFreemanDaily Hi there! Alicia - 3x cancer survivor, co-founder of #BCSM checking in to say hi and watch the chat. Great topic! #LCSM |
| Janet Freeman-Daily @JFreemanDaily My usual sidekick @LungCancerFaces is busy with grandmotherly duties tonight, so I'm grateful Stacey is my copilot tonight. #LCSM |
| Christine Qiong Wu @CQiongWu @JFreemanDaily @coffeemommy I'm Christine, #lcsm, @JFreemanDaily |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @stales @JFreemanDaily Welcome Alicia! {virtual hug} So excited to have you here! #lcsm #bcsm |
 | Sara Whitlock @sjwhitlock Sara here. Working on 10 years with stage IV NSCLC! #LCSM |
 | Cori @coristarlit @JFreemanDaily @coffeemommy Cori here, joining from Northern CA! #LCSM |
| Janet Freeman-Daily @JFreemanDaily Hi Tiffini, Christine and Alicia! Thanks for dropping in. #LCSM |
| Alicia C. Staley @stales @coffeemommy @JFreemanDaily hey there! how are you. #LCSM |
| Janet Freeman-Daily @JFreemanDaily Welcome Cori and Sara! #LCSM |
 | Peggy Dennis @peggyddennis Peggy here from Denver. Waiting on biopsy results to determine eligibility for 3 clinical trials @ UCH #lcsm |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @JFreemanDaily @LungCancerFaces No adult supervision! Look out y'all! ❤️ #lcsm #bcsm #gyncsm |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @peggyddennis Welcome Peggy! Sending {hugs} for the wait... waiting is the worst. #lcsm |
| Janet Freeman-Daily @JFreemanDaily @stales @coffeemommy Rolling with the evolving #COVID19Seattle situation. #LCSM |
| Janet Freeman-Daily @JFreemanDaily Hi Peggy! #LCSM |
| Janet Freeman-Daily @JFreemanDaily If you are new to Twitter chats and/or #LCSM Chat, you might find our primer on how to participate helpful https://t.co/5g28sSQQLb |
| Janet Freeman-Daily @JFreemanDaily Please remember to use #lcsm in all your tweets so others participating in the chat can see them. #LCSM |
 | Laura Greco @lgreco_ny Greetings from upstate NY! #lcsm |
| Janet Freeman-Daily @JFreemanDaily I will announce FOUR topics (T1 T2 etc). Pls label your answers with T1, T2, etc to make transcript easier to follow. #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @JFreemanDaily @stales And #HIMSS20 was cancelled due to #COVID19 so I'm looking at an open calendar next week 🙃 #lcsm |
| Janet Freeman-Daily @JFreemanDaily We’ll start with Topic T1 in a minute …#LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @lgreco_ny *happy dance* LAURA! {hug} #lcsm |
| Janet Freeman-Daily @JFreemanDaily @lgreco_ny Hi Laura! #LCSM |
| Janet Freeman-Daily @JFreemanDaily T1. What are the barriers to cancer clinical trial participation and enrollment? #LCSM |
| Christine Qiong Wu @CQiongWu @lgreco_ny how are you? #lcsm @lgreco_ny |
| Sara Whitlock @sjwhitlock T1. Admission criteria. #LCSM |
| Inspire @InspireIsHealth Hi all, John Novack from Inspire checking in to #LCSM. |
| Janet Freeman-Daily @JFreemanDaily @ProjectBreath Hey Lillian! Welcome. #LCSM |
| Inspire @InspireIsHealth RT @JFreemanDaily: T1. What are the barriers to cancer clinical trial participation and enrollment? #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy Awareness, restrictive exclusion criteria, geographic access, financial & logistical considerations all remain significant barriers for many across all cancer types. Also big confusion around what clinical trials are and are not. T1 #lcsm #bcsm #gyncsm |
| Laura Greco @lgreco_ny @JFreemanDaily T1: I think time and money are two big ones. #lcsm |
| Janet Freeman-Daily @JFreemanDaily #Clinicaltrials aim to understand the risks and benefits of a treatment in a specific population or disease. Hopefully the results can be applied to all who have the disease. #LCSM https://t.co/I8LdPSzNfK |
| Tiffini Joseph @Smiles4Nana So, I just switched careers and now am a LC research RN. So far, The inclusion/exclusion criteria can be so tight #LCSM |
| kristen kimball @KimballKristen T1 I expect some barriers include lack of knowledge on part of patient, perhaps even physician; distance from major research centers where trials are held; and false perception that they “could get the placebo” #LCSM |
| Janet Freeman-Daily @JFreemanDaily Hi John and Narjust! #LCSM |
| Alicia C. Staley @stales RT @JFreemanDaily: #Clinicaltrials aim to understand the risks and benefits of a treatment in a specific population or disease. Hopefully the results can be applied to all who have the disease. #LCSM https://t.co/I8LdPSzNfK |
| Tiffini Joseph @Smiles4Nana T1 and not enough referrals to studies #LCSM |
| Janet Freeman-Daily @JFreemanDaily Globally, about 3/4 of people surveyed were willing to participate in a clinical trial, yet only 8% of adult US cancer patients participate in NCI or industry clinical trials. Why?#LCSM |
| Alicia C. Staley @stales Please join in #LCSM chat going on now. |
| Alicia C. Staley @stales RT @JFreemanDaily: T1. What are the barriers to cancer clinical trial participation and enrollment? #LCSM |
| Janet Freeman-Daily @JFreemanDaily Patients site many reasons for not participating in clinical trials #LCSM https://t.co/yZjD7tZLsJ |
| Laura Greco @lgreco_ny @Smiles4Nana Yes! Too often, doctors only will refer to trials within their institution. It happened to me more than once. #lcsm |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @Smiles4Nana This is a big one. Most clinical trials are run out of academic medical centers, community oncology practices don't necessarily have the time/resources to trial find. #lcsm |
| Janet Freeman-Daily @JFreemanDaily A study by Unger found that more than half of all cancer patients did not participate in #clinicaltrials because no trial was available. #LCSM |
| Peggy Dennis @peggyddennis #Ditto on inclusion/exclusion. Patient numbers for enrollment can be too small #lcsm |
| Sara Whitlock @sjwhitlock So many think it is last ditch option #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy RT @KimballKristen: T1 I expect some barriers include lack of knowledge on part of patient, perhaps even physician; distance from major research centers where trials are held; and false perception that they “could get the placebo” #LCSM |
| Inspire @InspireIsHealth RT @JFreemanDaily: Patients site many reasons for not participating in clinical trials #LCSM https://t.co/yZjD7tZLsJ |
| Janet Freeman-Daily @JFreemanDaily Patients with rare diseases may spend a long time searching for a clinical trial that will accept them. https://t.co/FuJS6NtdMw #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @JFreemanDaily Having spent an hour of my day working on a response to the @nlm_news effort underway to “Modernize Clinical Trials” https://t.co/jfv4XBcJxw, I would say some of the issues are in the way the information is cataloged/tagged. HARD to search. #lcsm |
| Alicia C. Staley @stales RT @JFreemanDaily: Patients with rare diseases may spend a long time searching for a clinical trial that will accept them. https://t.co/FuJS6NtdMw #LCSM |
| Janet Freeman-Daily @JFreemanDaily Topic T2 is coming up … #LCSM |
| Tiffini Joseph @Smiles4Nana T1: not enough patient reimbursement for copays when providing standard of care, travel expenses etc... #LCSM |
| Alicia C. Staley @stales RT @JFreemanDaily: A study by Unger found that more than half of all cancer patients did not participate in #clinicaltrials because no trial was available. #LCSM |
 | Barbara L. Kornblau @BarbaraKornblau RT @JFreemanDaily: Patients with rare diseases may spend a long time searching for a clinical trial that will accept them. https://t.co/FuJS6NtdMw #LCSM |
| Alicia C. Staley @stales RT @coffeemommy: @Smiles4Nana This is a big one. Most clinical trials are run out of academic medical centers, community oncology practices don't necessarily have the time/resources to trial find. #lcsm |
| Cori @coristarlit @JFreemanDaily I think Geography and finances are two biggest reasons. For those who don’t live close to the institution that is doing the clinical trial, it is going to cost an arm and a leg to participate. #LCSM |
| Janet Freeman-Daily @JFreemanDaily Barriers to clinical trials may be structural (finding an available trial where the patient is able to go), clinical (patient characteristics must meet eligibility requirements), physician-based (discussing/offering trials), or patient-based (concerns about enrollment). #LCSM |
| Janet Freeman-Daily @JFreemanDaily T2. How might awareness of clinical trials be increased?#LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @sjwhitlock This is such a big issue. Still a big misconception in more than just the patient community. #lcsm |
| Christine Qiong Wu @CQiongWu @JFreemanDaily I think the lack of information is an obstacle. For example, for phase 1 clinical trial, how much is the success rate (how many of phase 1 clinical trials entered phase 2?) What is the phase 1 clinical trial like? #lcsm @JFreemanDaily |
 | Participatory Medicine @S4PM RT @ePatientDave: Love it! "Help me see the dragon I'm slaying": Love it! "Help me see the dragon I'm slaying": pathologists meeting w patients, in @ArchivesPath. @S4PM Blog @Wellforce pathologist @LIJJoseph, @ALBoothMD, radiologist @SubatomicDoc and #lcsm patient @1111linno cc @TeamInspire & *all* e-patients https://t.co/a8WafzyQjo |
| Laura Greco @lgreco_ny T1: Time it takes to get onto trial could matter too. It took more than three weeks to get on mine and I was worried. Some may not be able to wait. #lcsm |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @wi_qiong @JFreemanDaily Or, for many, what do the phases even mean? Definitely varied levels of health and scientific literacy out there. We need to meet people where they are in that respect! #lcsm |
| Peggy Dennis @peggyddennis T2 Make it easier for patients to find clinical trials via web sites that specialize in C/T's. Then offer help with followthrough. #lcsm |
| Tiffini Joseph @Smiles4Nana It would be nice if there was a registry that oncologists could participate in that could identify some basic qualifying factors for referral/notification to study centers #LCSM |
| kristen kimball @KimballKristen @lgreco_ny and if the trial requires a long washout period from former treatment, that is frightening #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @lgreco_ny Oooh! And can we talk "washout periods" - no bueno. #lcsm |
| Cori @coristarlit Whoops. Forgot #LCSM tag |
| Laura Greco @lgreco_ny T2: I think patient testimonials can be quite powerful. #lcsm |
| Inspire @InspireIsHealth RT @JFreemanDaily: T2. How might awareness of clinical trials be increased?#LCSM |
| Showtime @withspin RT @JFreemanDaily: A study by Unger found that more than half of all cancer patients did not participate in #clinicaltrials because no trial was available. #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @JFreemanDaily Awareness gaps & needs are two-sided. Often many clinicians are not aware of best clinical trial options & hard to get a handle over that much swiftly changing information. Advocacy groups can (and do!) educate patients but we need better search tools to find the best fit. #lcsm |
| Inspire @InspireIsHealth RT @coffeemommy: @JFreemanDaily Having spent an hour of my day working on a response to the @nlm_news effort underway to “Modernize Clinical Trials” https://t.co/jfv4XBcJxw, I would say some of the issues are in the way the information is cataloged/tagged. HARD to search. #lcsm |
| Janet Freeman-Daily @JFreemanDaily @coristarlit Yep, that #LCSM tag really helps those of us in the chat see your tweets! |
| Tiffini Joseph @Smiles4Nana Agree!! |
| Alicia C. Staley @stales RT @coristarlit: Whoops. Forgot #LCSM tag |
| Laura Greco @lgreco_ny RT @KimballKristen: @lgreco_ny and if the trial requires a long washout period from former treatment, that is frightening #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @peggyddennis Hoping that the Clinical Trials Modernization Effort can address some of those things upfront. The comment period is currently OPEN and closes 3/14. Add your thoughts here: https://t.co/5PYweVPWu0 #lcsm #bcsm |
 | Lecia Sequist, MD, MPH @LeciaSequist #LCSM joining late from Boston |
| Cori @coristarlit @JFreemanDaily T2. I don’t know if awareness is a problem. I think most patients know clinical trials are out there, but they assume their doctor will tell them its an option. Many don’t realize that if a trial isn’t at that doctors hospital, it is very likely they don’t know about it. #LCSM |
 | april knowles @akknowles1 @UppityCancerP I always say too bad Buddha didn’t get cancer. It would have saved him a lot of time. You get cancer and are automatically enlightened. #cancer #bcsm #LCSM |
| Laura Greco @lgreco_ny RT @coffeemommy: @peggyddennis Hoping that the Clinical Trials Modernization Effort can address some of those things upfront. The comment period is currently OPEN and closes 3/14. Add your thoughts here: https://t.co/5PYweVPWu0 #lcsm #bcsm |
| Janet Freeman-Daily @JFreemanDaily Alas, #LCSM Chat retweets from @lcsmchat account are languishing without the nimble fingers of @LungCancerFaces... #LCSM |
 | Dr. David Tom Cooke @DavidCookeMD A2 I think some of the cultural barriers should be addressed. For instance, many in the African-American communities are reluctant to participate in CT because of the Tuskegee syphilis debacle. #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @coffeemommy: @peggyddennis Hoping that the Clinical Trials Modernization Effort can address some of those things upfront. The comment period is currently OPEN and closes 3/14. Add your thoughts here: https://t.co/5PYweVPWu0 #lcsm #bcsm |
| Lecia Sequist, MD, MPH @LeciaSequist @Smiles4Nana Such a resource exists (https://t.co/tRPn2C2DNo) but unfortunately it's not as user-friendly as one might wish #LCSM |
| Janet Freeman-Daily @JFreemanDaily Thanks for sharing that link, @coffeemommy! #Cancer patient advocates, send your suggestions in SOON! #LCSM |
| kristen kimball @KimballKristen T2 Outreach should address the fact that, at least for #lungcancer , clinical trials are NOT the “last option” but may very well be the first. #LCSM |
| Janet Freeman-Daily @JFreemanDaily @LeciaSequist Welcome Lecia! And apologies to any I've neglected to welcome. #LCSM |
| Tiffini Joseph @Smiles4Nana @LeciaSequist Yes, more user friendly. Something simple. Pt has dx, entered into system and study nurse is alerted. Even if not large scale. Would be helpful in center participating in trials. There are many patients that still don’t get referred #LCSM |
| Janet Freeman-Daily @JFreemanDaily We’ll shift to Topic T3 next … #LCSM |
| Laura Greco @lgreco_ny @LeciaSequist @Smiles4Nana It is also frequently wrong and out of date. That search engine needs to change! #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @LeciaSequist: @Smiles4Nana Such a resource exists (https://t.co/tRPn2C2DNo) but unfortunately it's not as user-friendly as one might wish #LCSM |
| Laura Greco @lgreco_ny RT @JFreemanDaily: Thanks for sharing that link, @coffeemommy! #Cancer patient advocates, send your suggestions in SOON! #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @DavidCookeMD: A2 I think some of the cultural barriers should be addressed. For instance, many in the African-American communities are reluctant to participate in CT because of the Tuskegee syphilis debacle. #LCSM |
| Christine Qiong Wu @CQiongWu @coristarlit @JFreemanDaily I supposed the doctors should be the first one to know, should they? #lcsm |
| Janet Freeman-Daily @JFreemanDaily @DavidCookeMD Hey there @DavidCookeMD! #LCSM |
| Janet Freeman-Daily @JFreemanDaily T3. How might eligibility requirements be modernized to help increase clinical trial enrollment? #LCSM |
| Sara Whitlock @sjwhitlock T2. Aren’t they revamping the clinical trial site? #LCSM |
| Dr. David Tom Cooke @DavidCookeMD Ola! #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @LeciaSequist @Smiles4Nana Indeed, thus the CT Modernization Effort by @nlm_news Yes, I feel like a broken record tonight but hoping you all share your thoughts - and I'm happy to help if you want to submit! The comment period is currently OPEN and closes 3/14. #lcsm #bcsm https://t.co/5PYweVPWu0 |
| Dr. David Tom Cooke @DavidCookeMD A3, remove the "other solid organ tumor within 5 years" exclusion. #LCSM |
| Laura Greco @lgreco_ny @coffeemommy @LeciaSequist @Smiles4Nana @nlm_news Do you have a sample template of comments? #lcsm |
| Janet Freeman-Daily @JFreemanDaily Did you know that even when a clinical trial is available, 21.5% patients are ineligible due to exclusion criteria? #LCSM https://t.co/uZvpxZyhKI |
| Sara Whitlock @sjwhitlock @JFreemanDaily Not shocked AT ALL!#LCSM |
| Janet Freeman-Daily @JFreemanDaily 3 common characteristics (history of cancer, brain mets, high creatinine) can exclude almost half of advanced-stage NSCLC patients from clinical trials. Broadening these eligibility criteria would make almost twice as many patients eligible. #LCSM https://t.co/9sGA6r8p8j |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @lgreco_ny @LeciaSequist @Smiles4Nana @nlm_news I do not. I tend to write mine as a letter and upload but the link allows you to fill in the comment boxes. Working on my personal letter now and working with advocacy groups to create a multi-institution letter. Happy to include you! #lcsm |
| Alicia C. Staley @stales RT @JFreemanDaily: Did you know that even when a clinical trial is available, 21.5% patients are ineligible due to exclusion criteria? #LCSM https://t.co/uZvpxZyhKI |
| Laura Greco @lgreco_ny Yes! #lcsm |
| Dr. David Tom Cooke @DavidCookeMD Agree. I believe many trials are loosening the creatinine restrictions. #LCSM |
| Janet Freeman-Daily @JFreemanDaily As science advances, trials are becoming more complex. The number of exclusion criteria in #lungcancer clinical trials has been increasing. #LCSM https://t.co/sAGxPSyMP1 |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @DevikaDasMD @JFreemanDaily This is in process - comment period is open until 3/14 https://t.co/5PYweVPWu0 #lcsm #bcsm #gyncsm |
 | patty spears @paspears88 @JFreemanDaily My favorite figure from this paper...an aha moment in a graph. Patients aren't the issue, the system needs to change and trials need to include more patients. #lcsm |
| Lecia Sequist, MD, MPH @LeciaSequist @JFreemanDaily @Lungevity has done so much great advocacy to push pharma and FDA on this front. Things like not excluding pts w/ a h/o another cancer, with brain mets. They are working on remote consenting now #LCSM |
| Cori @coristarlit @wi_qiong @JFreemanDaily In my experience there are hundreds of clinical trials out there and 99% of onc’s cannot keep up to date with all of them. Especially since the criteria varies so widely. They do know the trials that they currently have at their own hospital. #LCSM |
| Laura Greco @lgreco_ny T3: drop whenever possible the brain met exclusion. #lcsm |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @sjwhitlock Yes, yes and they're looking for feedback now! #lcsm https://t.co/5PYweVPWu0 |
| Lecia Sequist, MD, MPH @LeciaSequist This 👇 |
| Laura Greco @lgreco_ny T3: how about trial design with patient input? #lcsm |
| Janet Freeman-Daily @JFreemanDaily @LeciaSequist @LUNGevity Some of my charts tonight were provided by the marvelous Upal Basu Roy of @LUNGevity -- thanks buddy. #LCSM |
| Dr. David Tom Cooke @DavidCookeMD A3 There is also geographic disparities. Travel distances to participate in clinical trials. Sometimes patients are forced to move. In those cases, many of course will not any bother. #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @JFreemanDaily And if anyone would like to work on this together, I am working on a letter now, would be happy to have people co-sign! #lcsm |
| Dr. David Tom Cooke @DavidCookeMD Or even over the phone translators. #LCSM |
| Laura Greco @lgreco_ny T3: Let's design trials by pairing drugs that actually make sense rather than drugs we can get from manufacturer easily. #lcsm |
| Inspire @InspireIsHealth RT @JFreemanDaily: Did you know that even when a clinical trial is available, 21.5% patients are ineligible due to exclusion criteria? #LCSM https://t.co/uZvpxZyhKI |
| Inspire @InspireIsHealth RT @coffeemommy: @peggyddennis Hoping that the Clinical Trials Modernization Effort can address some of those things upfront. The comment period is currently OPEN and closes 3/14. Add your thoughts here: https://t.co/5PYweVPWu0 #lcsm #bcsm |
| Dr. David Tom Cooke @DavidCookeMD Would require targeted community center partnerships. #LCSM |
 | Harpreet Singh, MD @harpreet_md @LeciaSequist @JFreemanDaily @LUNGevity @FDAOncology has several guidances out on modernizing eligibility criteria - including patients with brain metastasis abs organ dysfunction. #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @JFreemanDaily Must structure trials in way that individuals w/ comorbidities can participate. Cancer remains disease of aging (despite young age many of us were dx'd!) and, with age, comes other health issues of aging. We eliminate many participants based on unrealistic requirements. #lcsm |
| Inspire @InspireIsHealth RT @JFreemanDaily: T3. How might eligibility requirements be modernized to help increase clinical trial enrollment? #LCSM |
| Sara Whitlock @sjwhitlock Few of us who have had multiple treatments are without some organ damage#lcsm |
| Showtime @withspin RT @JFreemanDaily: Patients with rare diseases may spend a long time searching for a clinical trial that will accept them. https://t.co/FuJS6NtdMw #LCSM |
| Janet Freeman-Daily @JFreemanDaily @harpreet_md @LeciaSequist @LUNGevity @FDAOncology @ASCO and Friends of Cancer Research published several reports last year on the modernizing of eligibility criteria. It was the basis of a presentation on relaxing trials eligibility requirements I gave at #WCLC19 last year. #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @lgreco_ny Yes! And I love the adaptive trial design of iSPY2. Would like to see more adaptive designs as well as flexible/virtual trial sites to remove the travel burden. #lcsm #bcsm https://t.co/NU8zfqEEPB |
 | Dr. Amy C. Moore @acmoorephd RT @LungCancerFaces: Why aren’t more cancer patients participating in clinical trials? There are a number of reasons. Let’s identify them & brainstorm solutions during this Thursday’s #LCSM Chat at 8 pm Eastern/5 pm Pacific. Read more here: https://t.co/vtXd2kPKyi and join the conversation! #hcsm https://t.co/HOK9DSAzwA |
| patty spears @paspears88 Here is my recent editorial on this topic. I have the Unger and the Harvey articles referenced in it. I also have the @ASCO @CancerResrch modernizing eligibility references in it. All advocates need to become educated about all these issues. https://t.co/UZiX7u6yQ7 #lcsm |
| Dr. David Tom Cooke @DavidCookeMD RT @paspears88: Here is my recent editorial on this topic. I have the Unger and the Harvey articles referenced in it. I also have the @ASCO @CancerResrch modernizing eligibility references in it. All advocates need to become educated about all these issues. https://t.co/UZiX7u6yQ7 #lcsm |
| Dr. Amy C. Moore @acmoorephd RT @JFreemanDaily: A study of lung cancer rates in young adults in 40 countries across five continents found increasingly higher #lungcancer rates in young women compared to men, and it can't be explained by smoking history. #LCSM https://t.co/UfD7bUrj66 |
 | 🐾 JOANNE 🐾 @JoanneK64 Southern Ontario has joined the convo #LCSM |
| Janet Freeman-Daily @JFreemanDaily This is where you can find all the info on ASCO/Friends of Cancer Research work on modernizing clinical trial eligility. #LCSM |
| Dr. David Tom Cooke @DavidCookeMD RT @JFreemanDaily: This is where you can find all the info on ASCO/Friends of Cancer Research work on modernizing clinical trial eligility. #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @NarjustDumaMD @JFreemanDaily @tmprowell Indeed. She is a great advocate in all sorts of ways and valued part of our community! #lcsm #bcsm |
| Janet Freeman-Daily @JFreemanDaily RT @paspears88: Here is my recent editorial on this topic. I have the Unger and the Harvey articles referenced in it. I also have the @ASCO @CancerResrch modernizing eligibility references in it. All advocates need to become educated about all these issues. https://t.co/UZiX7u6yQ7 #lcsm |
| Janet Freeman-Daily @JFreemanDaily @paspears88 @ASCO @CancerResrch Terrific Patty, thank you! #LCSM |
 | Sally James @jamesian @coffeemommy @wi_qiong @JFreemanDaily This isn't written in especially EASY language, but guide to Phases of clinical trials https://t.co/5Yxgdt1uk1 #healthliteracy #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @coffeemommy: @lgreco_ny Yes! And I love the adaptive trial design of iSPY2. Would like to see more adaptive designs as well as flexible/virtual trial sites to remove the travel burden. #lcsm #bcsm https://t.co/NU8zfqEEPB |
| patty spears @paspears88 I just saw this on my twitter feed. Appropriate for this discussion. Still open for comments... increasing representation of older adults on clinical trials #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @coffeemommy: @JFreemanDaily Must structure trials in way that individuals w/ comorbidities can participate. Cancer remains disease of aging (despite young age many of us were dx'd!) and, with age, comes other health issues of aging. We eliminate many participants based on unrealistic requirements. #lcsm |
| Sally James @jamesian @coffeemommy @wi_qiong @JFreemanDaily Video version https://t.co/KQB7se3u1H #lcsm |
| Harpreet Singh, MD @harpreet_md @LeciaSequist @JFreemanDaily @LUNGevity @FDAOncology Efforts to publish this series of guidances @FDAOncology led by @DrJuliaBeaver #lcsm https://t.co/BDR1Jjaugb |
| Inspire @InspireIsHealth RT @jamesian: @coffeemommy @wi_qiong @JFreemanDaily Video version https://t.co/KQB7se3u1H #lcsm |
| Laura Greco @lgreco_ny RT @paspears88: Here is my recent editorial on this topic. I have the Unger and the Harvey articles referenced in it. I also have the @ASCO @CancerResrch modernizing eligibility references in it. All advocates need to become educated about all these issues. https://t.co/UZiX7u6yQ7 #lcsm |
| Inspire @InspireIsHealth RT @paspears88: Here is my recent editorial on this topic. I have the Unger and the Harvey articles referenced in it. I also have the @ASCO @CancerResrch modernizing eligibility references in it. All advocates need to become educated about all these issues. https://t.co/UZiX7u6yQ7 #lcsm |
| Janet Freeman-Daily @JFreemanDaily I would really like to see preclinical data made available to patients for consideration prior to joining a Phase 1 clinical trial. #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @jamesian @wi_qiong @JFreemanDaily But you nailed it Sally with the "isn't written in especially EASY language." It isn't, we must do better. Videos, articles, infographics... we can do better with #education and #healthliteracy #lcsm #bcsm |
| Lecia Sequist, MD, MPH @LeciaSequist #LCSM words I use to explain to those nervous about clinical trials: while we have lots of treatments for lung CA, we don't have infinite treatments. A trial that makes sense for you opens the door to an additional line of therapy, while also improving info for future pts |
| Charu Aggarwal, MD, MPH, FASCO @CharuAggarwalMD @JFreemanDaily A3. Some of the changes that are much needed are coming, inclusion of patients affected with HIV and brain mets #LCSM |
 | Julia Maués @itsnot_pink RT @paspears88: Here is my recent editorial on this topic. I have the Unger and the Harvey articles referenced in it. I also have the @ASCO @CancerResrch modernizing eligibility references in it. All advocates need to become educated about all these issues. https://t.co/UZiX7u6yQ7 #lcsm |
| Janet Freeman-Daily @JFreemanDaily And we DEFINITELY need all clinical trial data published--even when it's negative. How can we avoid making the same mistake in the future if we don't know about it? #LCSM |
 | Benjamin Vincent @BenjaminGVincen RT @paspears88: Here is my recent editorial on this topic. I have the Unger and the Harvey articles referenced in it. I also have the @ASCO @CancerResrch modernizing eligibility references in it. All advocates need to become educated about all these issues. https://t.co/UZiX7u6yQ7 #lcsm |
| Dr. David Tom Cooke @DavidCookeMD A3 Good words. Medical Oncologists are skilled at explaining clinical trials as opposed to surgeons. Not alot of neoadjuvant and adjuvant #LungCancer trials, and patients are skeptical. "Just want it out". #LCSM |
| Janet Freeman-Daily @JFreemanDaily 5:44 Topic T4 is coming up … #LCSM |
| Dr. David Tom Cooke @DavidCookeMD RT @JFreemanDaily: And we DEFINITELY need all clinical trial data published--even when it's negative. How can we avoid making the same mistake in the future if we don't know about it? #LCSM |
| Laura Greco @lgreco_ny RT @JFreemanDaily: I would really like to see preclinical data made available to patients for consideration prior to joining a Phase 1 clinical trial. #LCSM |
| Peggy Dennis @peggyddennis @JFreemanDaily That would be great! #lcsm |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy RT @JFreemanDaily: And we DEFINITELY need all clinical trial data published--even when it's negative. How can we avoid making the same mistake in the future if we don't know about it? #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @harpreet_md: @LeciaSequist @JFreemanDaily @LUNGevity @FDAOncology Efforts to publish this series of guidances @FDAOncology led by @DrJuliaBeaver #lcsm https://t.co/BDR1Jjaugb |
| Janet Freeman-Daily @JFreemanDaily RT @jamesian: @coffeemommy @wi_qiong @JFreemanDaily Video version https://t.co/KQB7se3u1H #lcsm |
| Laura Greco @lgreco_ny RT @coristarlit: @JFreemanDaily T2. I don’t know if awareness is a problem. I think most patients know clinical trials are out there, but they assume their doctor will tell them its an option. Many don’t realize that if a trial isn’t at that doctors hospital, it is very likely they don’t know about it. #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @paspears88: I just saw this on my twitter feed. Appropriate for this discussion. Still open for comments... increasing representation of older adults on clinical trials #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @jamesian: @coffeemommy @wi_qiong @JFreemanDaily This isn't written in especially EASY language, but guide to Phases of clinical trials https://t.co/5Yxgdt1uk1 #healthliteracy #lcsm |
| Julia Maués @itsnot_pink RT @JFreemanDaily: Did you know that even when a clinical trial is available, 21.5% patients are ineligible due to exclusion criteria? #LCSM https://t.co/uZvpxZyhKI |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @JFreemanDaily I simply cannot even amplify this comment enough... #lcsm #bcsm #clinicaltrials #Truth |
| Laura Greco @lgreco_ny RT @JFreemanDaily: And we DEFINITELY need all clinical trial data published--even when it's negative. How can we avoid making the same mistake in the future if we don't know about it? #LCSM |
| Lecia Sequist, MD, MPH @LeciaSequist @JFreemanDaily Agree completely but note in reality this can be a challenge. It can take unbelievable time and energy to get a small negative trial published. May be rewriting many times over for many journals. Whole process can take mult years and many give up mid-stream #LCSM |
| Janet Freeman-Daily @JFreemanDaily T4. How might financial, travel, and administrative barriers to clinical trial enrollment be reduced? #LCSM |
| Dr. David Tom Cooke @DavidCookeMD Need an open access Journal of Negative Trials. #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @LeciaSequist: @JFreemanDaily Agree completely but note in reality this can be a challenge. It can take unbelievable time and energy to get a small negative trial published. May be rewriting many times over for many journals. Whole process can take mult years and many give up mid-stream #LCSM |
| patty spears @paspears88 @JFreemanDaily There have been 4 published - Brain Metastasis, Comorbidities, Minimum Age, HIV Inclusion and there are 4 more coming.. #lcsm Kim et. al. PMID: 28968170 Lin et. al. PMID: 28968165 Lichtman et. al. PMID: 28968172 Uldrick et. al. PMID: 28968173 Gore et. al. PMID: 28968169 |
| Janet Freeman-Daily @JFreemanDaily RT @DavidCookeMD: A3 Good words. Medical Oncologists are skilled at explaining clinical trials as opposed to surgeons. Not alot of neoadjuvant and adjuvant #LungCancer trials, and patients are skeptical. "Just want it out". #LCSM |
| Laura Greco @lgreco_ny @JFreemanDaily The federal government must punish those who fail to report!!! #lcsm https://t.co/YGw9m4nPFA |
| Dr. David Tom Cooke @DavidCookeMD A4 Partner with industry: @Airbnb @Uber @lyft #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @LeciaSequist: #LCSM words I use to explain to those nervous about clinical trials: #LCSM words I use to explain to those nervous about clinical trials: while we have lots of treatments for lung CA, we don't have infinite treatments. A trial that makes sense for you opens the door to an additional line of therapy, while also improving info for future pts |
 | Percy Lee MD @PercyLeeMD Through team work @MDAndersonNews #radonc successfully treated our first #thoracic pt with @Elekta MR-linac. Rewarding to see how a talented team can focus energy to innovate better treatments with advanced technology for our patients. #lcsm @ACKoongMDPhD @cd_fuller @jihongw2 https://t.co/od6Pa62CJd |
| Charu Aggarwal, MD, MPH, FASCO @CharuAggarwalMD @lgreco_ny Most important. There is significant effort to include pts and advocates in clinical trial design. We must partner Ojibwa this important process #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @JFreemanDaily T4: In the words of the intrepid @1111linno, “Just please pay for my damn parking.” Seriously, it’s the little things that add up to be big things. Travel costs, parking fees, childcare, these may seem small but, when added up can prevent participation/retention in research #lcsm |
| Janet Freeman-Daily @JFreemanDaily @NarjustDumaMD Whatever happened to the Journal of Negative Results? #LCSM |
| Dr. David Tom Cooke @DavidCookeMD What's @PCORI is for. #LCSM |
| Sally James @jamesian @coffeemommy @wi_qiong @JFreemanDaily Another try. #lcsm #clinicaltrials https://t.co/FeJTvCzWMV |
| Tom Varghese Jr. MD, MS, MBA, FACS, MAMSE 🇺🇸 @TomVargheseJr RT @JFreemanDaily: And we DEFINITELY need all clinical trial data published--even when it's negative. How can we avoid making the same mistake in the future if we don't know about it? #LCSM |
| Dr. David Tom Cooke @DavidCookeMD Was that a thing? #LCSM |
| Sara Whitlock @sjwhitlock T4. I’m lucky my trial does reimburse me. I don’t understand why this doesn’t happen more. Pharm vs academia? Perhaps? #LCSM |
| Laura Greco @lgreco_ny RT @lgreco_ny: @JFreemanDaily The federal government must punish those who fail to report!!! #lcsm https://t.co/YGw9m4nPFA |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @jamesian @wi_qiong @JFreemanDaily Love this! Who is it from? #lcsm |
| Laura Greco @lgreco_ny RT @coffeemommy: @JFreemanDaily T4: @JFreemanDaily T4: In the words of the intrepid @1111linno, “Just please pay for my damn parking.” Seriously, it’s the little things that add up to be big things. Travel costs, parking fees, childcare, these may seem small but, when added up can prevent participation/retention in research #lcsm |
| Janet Freeman-Daily @JFreemanDaily RT @coffeemommy: @jamesian @wi_qiong @JFreemanDaily But you nailed it Sally with the "isn't written in especially EASY language." It isn't, we must do better. Videos, articles, infographics... we can do better with #education and #healthliteracy #lcsm #bcsm |
| Cori @coristarlit @JFreemanDaily T4. Reimbursement for travel expenses! It’s ridiculous that we have to shoulder this cost, especially when if we don’t live near it, after years it can be over 10 grand (yes, personal experience here). #LCSM |
| Charu Aggarwal, MD, MPH, FASCO @CharuAggarwalMD @JFreemanDaily A4. Clinical trials are attractive when they include fringe benefits- parking, flights, overnight stays. They are important! #LCSM |
| kristen kimball @KimballKristen @coffeemommy @JFreemanDaily @1111linno Ditto this tweet@coffeemommy! Parking, lodging, food... #LCSM |
| patty spears @paspears88 This was presented @ASCO 2019 by Don Harvey https://t.co/gS0yqsdAhY and https://t.co/PyZYE11EIh Quite incredible comparing traditional and broad eligibility... #lcsm |
 | Myositis Support and Understanding (MSU) @MyositisSupport RT @coffeemommy: @peggyddennis Hoping that the Clinical Trials Modernization Effort can address some of those things upfront. The comment period is currently OPEN and closes 3/14. Add your thoughts here: https://t.co/5PYweVPWu0 #lcsm #bcsm |
| Laura Greco @lgreco_ny @KimballKristen @coffeemommy @JFreemanDaily @1111linno Every time I talk about it, I am met with disbelief. #lcsm |
 | Narjust Florez, MD, FASCO @NarjustFlorezMD @CharuAggarwalMD @JFreemanDaily A4: Parking is so often overlooked. #LCSM |
| Lecia Sequist, MD, MPH @LeciaSequist @JFreemanDaily Agree but IRB's/ethics boards require informed consent forms to be written at 2nd-4th grade reading level and other comments in this chat ref trial info being too complicated. Answer may be giving supplemental info to savvy patients as appropriate? #LCSM |
| Cori @coristarlit @JFreemanDaily T4. Also, ability to get blood tests taken at a local hospital if you are not near the trial hospital. To have to fly or drive a long way to get a CBC done every 4 weeks at the clinical trial hospital is absolutely ridiculous. Massive financial cost and life interference. #LCSM |
| Janet Freeman-Daily @JFreemanDaily At its meeting last fall, SACHRP made recommendations about paying clinical trial participants that will hopefully make more IRBs comfortable with allowing clinical trials to pay for parking, give gift cards as thank yous, etc. https://t.co/8HHjmOr36R #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @paspears88: This was presented @ASCO 2019 by Don Harvey https://t.co/gS0yqsdAhY and https://t.co/PyZYE11EIh Quite incredible comparing traditional and broad eligibility... #lcsm |
| Janet Freeman-Daily @JFreemanDaily We’re in our final minutes - closing thoughts? #LCSM |
| kristen kimball @KimballKristen @JFreemanDaily I hadn’t realized IRBs are part of this problem? #LCSM |
| Sally James @jamesian @coffeemommy @wi_qiong @JFreemanDaily Here is link to page, a collaborative https://t.co/mkmLuTry81 patient-physician collaborative for lung disease. #lcsm |
| Sally James @jamesian @JFreemanDaily The delivery of communication that helps ppl make decisions is itself "health care." Should be paid for and designed carefully. #lcsm #healthliteracy |
| Laura Greco @lgreco_ny @sjwhitlock Academia certainly isn't pushing for it. #lcsm |
| Sara Whitlock @sjwhitlock As with most things it is a complicated issue. Needs attacks from all sides. #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @JFreemanDaily Clinical trials need revamping and there is currently an @nlm_news effort underway to “Modernize Clinical Trials” https://t.co/jfv4XBcJxw. The comment period closes 3/14. #lcsm #bcsm Add your thoughts here: https://t.co/5PYweVPWu0 |
| Janet Freeman-Daily @JFreemanDaily If we truly want to address #cancer disparities and achieve true diversity in clinical trial enrollment, we have to consider trial participants' cost of insurance deductibles and copays, travel, childcare, and time away from work. #LCSM |
| Laura Greco @lgreco_ny RT @coffeemommy: @JFreemanDaily Clinical trials need revamping and there is currently an @nlm_news effort underway to “Modernize Clinical Trials” https://t.co/jfv4XBcJxw. The comment period closes 3/14. #lcsm #bcsm Add your thoughts here: https://t.co/5PYweVPWu0 |
| Lecia Sequist, MD, MPH @LeciaSequist @sjwhitlock Agree financial help is super important for trials. Not all trial sponsors (pharma) offer this - it's a bit random which sponsor and which trials. Also, IRBs (institutional ethics board) have concerns about coercion/enticement which we need to address. Frustrating. Sigh....#LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @coffeemommy: @JFreemanDaily Clinical trials need revamping and there is currently an @nlm_news effort underway to “Modernize Clinical Trials” https://t.co/jfv4XBcJxw. The comment period closes 3/14. #lcsm #bcsm Add your thoughts here: https://t.co/5PYweVPWu0 |
| Janet Freeman-Daily @JFreemanDaily RT @jamesian: @JFreemanDaily The delivery of communication that helps ppl make decisions is itself "health care." Should be paid for and designed carefully. #lcsm #healthliteracy |
| Laura Greco @lgreco_ny @JFreemanDaily In the rare disease space, patient related travel costs are reimbursed every time. #lcsm |
| Janet Freeman-Daily @JFreemanDaily @KimballKristen Some IRBs are reluctant to approve ANY payment to clinical trial participants for fear they are coercing people to participate. #LCSM |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy @JFreemanDaily @nlm_news And, if you'd like help, guidance, thoughts about how to submit comments, I am HAPPY to help. My email is my first and last name at Gmail or you can DM me. We need all voices sharing while government ears are open. #lcsm #bcsm #clinicaltrials #patientexperience |
| kristen kimball @KimballKristen My husband @VoicesForUS Dave Kimball was in 3 clinical trials, and one of them was a home run - years of quality life added. Forever grateful and wish as many others as possible could benefit as much. #LCSM |
| Inspire @InspireIsHealth RT @JFreemanDaily: At its meeting last fall, SACHRP made recommendations about paying clinical trial participants that will hopefully make more IRBs comfortable with allowing clinical trials to pay for parking, give gift cards as thank yous, etc. https://t.co/8HHjmOr36R #LCSM |
| Laura Greco @lgreco_ny RT @JFreemanDaily: If we truly want to address #cancer disparities and achieve true diversity in clinical trial enrollment, we have to consider trial participants' cost of insurance deductibles and copays, travel, childcare, and time away from work. #LCSM |
| Peggy Dennis @peggyddennis Great topic. Would be great to revisit. #lcsm |
| Laura Greco @lgreco_ny @JFreemanDaily Yes! Coinsurance and co-pays for extra scans can pinch! #lcsm |
| Lecia Sequist, MD, MPH @LeciaSequist @lgreco_ny @sjwhitlock Not true Laura - many of us advocate very hard to pharma for this on behalf of our patients. There are lots of barriers unfortunately (see my other tweet a few min ago) - mainly pharma wanting to pay and IRB concerns #LCSM |
| kristen kimball @KimballKristen @JFreemanDaily Frankly that seems disingenuous at best and stupid at worst...#lcsm |
| Janet Freeman-Daily @JFreemanDaily Thanks everyone for joining #LCSM Chat today to discuss expanding access to clinical trials! Thanks especially to @coffeemommy for being my special guest tonight. See you next month on April 2! |
| Stacey Tinianov (she/her) MPH, BCPA @coffeemommy TY all for sharing your thoughts in the #lcsm chat & thank you to those of you from other cancer communities who joined in to chat about how we might improve access, experience & expand enrollment in clinical trials. And hugs to @JFreemanDaily for inviting me to participate. |
| Katsuaki Maehara Ph.D. 🇯🇵 @KatsuakiMaehara RT @LeciaSequist: #LCSM words I use to explain to those nervous about clinical trials: #LCSM words I use to explain to those nervous about clinical trials: while we have lots of treatments for lung CA, we don't have infinite treatments. A trial that makes sense for you opens the door to an additional line of therapy, while also improving info for future pts |
 | Gina @EAustin1969 RT @coffeemommy: TY all for sharing your thoughts in the #lcsm chat & thank you to those of you from other cancer communities who joined in to chat about how we might improve access, experience & expand enrollment in clinical trials. And hugs to @JFreemanDaily for inviting me to participate. |
| Janet Freeman-Daily @JFreemanDaily RT @coffeemommy: TY all for sharing your thoughts in the #lcsm chat & thank you to those of you from other cancer communities who joined in to chat about how we might improve access, experience & expand enrollment in clinical trials. And hugs to @JFreemanDaily for inviting me to participate. |
| Dr. David Tom Cooke @DavidCookeMD Awesome! Great work as usual @JFreemanDaily #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @coffeemommy: @JFreemanDaily @nlm_news And, if you'd like help, guidance, thoughts about how to submit comments, I am HAPPY to help. My email is my first and last name at Gmail or you can DM me. We need all voices sharing while government ears are open. #lcsm #bcsm #clinicaltrials #patientexperience |
| Katsuaki Maehara Ph.D. 🇯🇵 @KatsuakiMaehara RT @CharuAggarwalMD: Circulating MicroRNA Profiles useful biomarker for Lung Cancer Detection in Symptomatic Patients. This is a vy important study that details a complementary modality to increase detection of #NSCLC @JAMAOnc #LiquidBiopsy @lcsmchat #LCSM https://t.co/kWZOt4xo7w |
 | Denny Keller @hrblock_21 RT @TakedaOncology: It's the strength and bravery that people living with #cancer show daily that fuels our teams' commitment to being more effective & efficient when developing new medicines. #tbt #lcsm #leusm https://t.co/irvZWYyA7e |
| Janet Freeman-Daily @JFreemanDaily @DavidCookeMD Check out this version: https://t.co/aOHGSAHv54 #LCSM |
| Janet Freeman-Daily @JFreemanDaily RT @coffeemommy: @JFreemanDaily T4: @JFreemanDaily T4: In the words of the intrepid @1111linno, “Just please pay for my damn parking.” Seriously, it’s the little things that add up to be big things. Travel costs, parking fees, childcare, these may seem small but, when added up can prevent participation/retention in research #lcsm |
#LCSM content from Twitter.